 | |
| Company type | Subsidiary |
|---|---|
| Founded | 2010; 14 years ago (2010) |
| Founder | Fertram Sigurjonsson |
| Headquarters | Ísafjörður, Iceland |
| Area served | Iceland, Switzerland, and United States |
| Key people | Fertram Sigurjonsson (CEO) |
| Products |
|
| Revenue | 25,492,874 Euro (2021)  |
| Number of employees | 196 (2021) |
| Subsidiaries | Phytoceuticals AG |
| Website | kerecis |
Kerecis is an Icelandic company that uses fish skins to treat wounds. The decellularized skin of the Atlantic cod is used as a graft, which increases the elasticity, tensile strength, and compressibility of the wound.
Kerecis has subsidiaries in Switzerland and the United States. It is based in Ísafjörður, Iceland.
In July 2023, Kerecis was sold to Danish company Coloplast for 1.2 billion USD.
History
Fertram Sigurjonsson observed in 2009 that the skin of the fish and qualities, which are similar to those of human skin, expedited the latter's regeneration, particularly in the case of acute or chronic wounds. Based on his discovery, he founded Kereceis in 2013.
Kerecis Omega-3 fish skin was cleared for use by the FDA in 2013 for the treatment of chronic and acute wounds. In Europe, Kerecis Omega-3 Wound was first CE marked in 2012.
In 2016, Omega3 Wound, a fish skin treatment developed by Kereceis, was approved by the US Food and Drug Administration. In the same year, Kerecis established headquarters in Arlington, Virginia.
In 2019, Kerecis acquired Phytoceuticals AG, a Swiss company active in the life sciences sector, that has since changed its name to Kerecis AG. In the same year, Emerson Collective acquired a stake in Kerecis.
In 2020, Kerecis received an award given by Vaxtarsprotinn, a joint project of the Confederation of Icelandic Industries, the Confederation of Start-up Companies, Icelandic Research Center, and Reykjavík University.
In 2021, FDA approved Kerecis Omega3 SurgiBind, fish-skin for surgical use that is useful in plastic and reconstructive surgery.
The company was valued at more than 100 million euros in 2021. Kereceis also works on medical research with the US Armed Forces and provides the grafts to branches of the military.
In August 2022, Kerecis raised $100 million in funding from investors, including Kirkbi, the investment arm of the Christiansen family that founded Lego Group, valuing the company at $620 million.
References
- "Kerecis allt að 30 milljarða króna virði". Morgunblaðið.
- "Kerecis bíður færis á yfirtökum". Fréttablaðið.
- Hannan, Daniel (October 25, 2020). "Taking back control of fishing could be an enormous growth opportunity for Britain". The Daily Telegraph.
- ^ "Dans le poisson islandais, rien ne se perd, tout se transforme". Le Monde. October 16, 2021.
- "Kerecis | Fish-Skin Technology |". May 20, 2021.
- "Ólafur Ragnar kominn í stjórn Kerecis". Fréttablaðið.
- ^ "FDA Approves Kerecis' Implantable Fish-Skin Product". Iceland Monitor.
- "Tekjur Kerecis þrefaldist og verði þrír milljarðar". Fréttablaðið.
- "Ein stærstu kaup Íslandssögunnar". Morgunblaðið (in Icelandic). 7 July 2023. Retrieved 7 July 2023.
- "Biotech Company Kerecis to Be Listed Abroad". Iceland Monitor.
- ^ "Kerecis valið Vaxtarsproti ársins". Morgunblaðið.
- "Using Fish Skin to Heal Wounds". Iceland Monitor.
- ^ "Fish Skin for Human Wounds: Iceland's Pioneering Treatment". Bloomberg Businessweek.
- ^ "Alaska's seafood industry by the numbers, plus fish skin's medical applications and antibiotics in Chilean salmon". Anchorage Daily News.
- "Kerecis Ltd. :: Medtech Insight".
- ^ Lake, Sydney (January 25, 2021). "Arlington biotech company names CFO".
- "Ólafur Ragnar í stjórn Kerecis". Fréttablaðið.
- "Emerson Collective eignast hlut i Kerecis". Fréttablaðið.
- "Dans le poisson islandais, rien ne se perd, tout se transforme". October 16, 2021 – via Le Monde.
- Torrance, Jack (June 24, 2018). "Iceland: From crisis to hotspot, 10 years on from the financial crisis". The Telegraph.
- "Lego Billionaires Invest in Fish-Skin Biotech From Iceland". Bloomberg.